Cohance Lifesciences announces resignation of CEO

28-Jul-2025 | 18:52

With effect from 31 July 2025

Cohance Lifesciences announced the resignation of Dr. Sudhir Kumar Singh, who looks after the CDMO business, as Chief Executive Officer of the Company with effect from 31 July 2025.